Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci

American Journal of Pathology

Volumn 160, Issue 5, 2002, Pages 1555-1560

  Pierce, Robert H ^a   Vail, Mary E ^a   Ralph, Leah ^a   Campbell, Jean S ^a   Fausto, Nelson ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; LIVER CANCER; LIVER CARCINOGENESIS; MALE; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 0036097789     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61101-7     Document Type: Article

References (22)

1. Bcl-2: An antidote to programmed cell death
2. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
3. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters
4. Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regression
5. Quantitative analysis of tumor initiation in rat liver: Role of cell replication and cell death (apoptosis)
6. Apoptosis and multistage carcinogenesis in rat liver
7. High, persistent hepatocellular proliferation and apoptosis precede hepatocarcinogenesis in growth hormone transgenic mice
8. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor α
9. Bcl-2 expression delays hepatocyte cell cycle progression during liver regeneration
10. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice
11. Rapid development of hepatic tumors in transforming growth factor α transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital
12. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor α transgenic mice
13. Bcl-2 expression delays mammary tumor development in dimethylben-z(a)anthracene-treated transgenic mice
14. Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model
15. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation
16. Regulation of cell division cycle progression by bcl-2 expression: A potential mechanism for inhibition of programmed cell death
17. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry
18. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry
19. Inverse correlation between bcl-2 expression and cell growth fraction in human endometrial adenocarcinoma tissue
20. p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients
21. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma
22. BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: An Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory study